A new study by the University of Turku and Turku University Hospital in Finland investigated the origin of ataxia in the brain of patients with stroke. A significant number of the stroke lesions in the patients were located outside the cerebellum.
An international research group led by researchers from the University of Turku and Turku University Hospital in Finland has succeeded in identifying the probable origin of stuttering in the brain.
Regular high caffeine consumption affects dopamine function in patients with Parkinson’s disease, shows a new international study led by the University of Turku and Turku University Hospital in Finland. Caffeine consumption before undergoing diagnostic brain dopamine imaging may also affect the imaging results.
Brain researchers from Turku share a strong passion for research and an ability to utilise state-of-the-art technology. PET imaging has provided a window into brain mechanisms, e.g. the principles of addiction or the progress of multiple sclerosis. Brain research is connected to the research and practice of patient care at the University of Turku and Turku University Hospital. This enables the researchers to have a firm grasp on what kind of research can help the patients and allows the quick utilisation of newly acquired expertise.
Researchers at the University of Turku and Turku University Hospital in Finland have shown that bodily sensations related to emotions are altered by the neurological disorder Parkinson's disease.
In a new study, researchers from the University of Turku showcased that the way our brain processes information is fundamentally altered during hypnosis. The research helps to understand how hypnosis produces changes in a hypnotised person’s behaviour and subjective experiences.
A new study conducted at the University of Turku shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson’s disease later in life. The increased risk may be due to alterations in the brain’s dopamine system caused by dopamine receptor antagonists or neurobiological effects of schizophrenia.
The European Association of Neurosurgical Societies (EANS) has nominated an original innovative clinical research article conducted at the University of Turku and Turku University Hospital as one of the three best clinical papers of the years 2019–2020. The first author of the article, Specialising Medical Doctor Iftakher Hossain, was also selected for the 3rd position of the Aesculap EANS Research Prize 2020.
A company based in Turku, PianoDuo ConFuego Company Oy, is donating €100,000 to the University of Turku. The donation will be allocated to neurological research on the impact of listening to music on the results of treating patients with brain diseases. The donation event was organised on 19 December 2019.